BUSINESS COMBINATIONS (Tables)

3 Months Ended

Dec. 31, 2021

Business Acquisition [Line Items]

Schedule of unaudited pro forma information

	Three Months Ended		Three Months Ended
	December 31, 2021		December 31, 2020
Total revenues	$	111,025	$	89,077
Net income (loss)		(85,841)		(35,324)

HistoTox Labs

Business Acquisition [Line Items]

Schedule of purchase price allocation

	Preliminary
	Allocation as of
	December 31, 2021
Assets acquired and liabilities assumed:
Accounts receivable		982
Unbilled revenues		337
Operating lease ROU asset		2,239
Property and equipment		4,021
Intangible assets		8,500
Other Assets		25
Goodwill		9,129
Accounts payable		(132)
Accrued expenses		(266)
Customer advances		(207)
Operating lease liability		(2,239)
	$	22,389

Bolder BioPATH

Business Acquisition [Line Items]

Schedule of purchase price allocation

	Preliminary
	Allocation as of
	December 31, 2021
Assets acquired and liabilities assumed:
Accounts receivable		2,258
Unbilled revenues		1,798
Prepaid expenses		6
Operating lease ROU asset		2,750
Property and equipment		6,609
Intangible asset		12,500
Other assets		70
Goodwill		36,223
Accounts payable		(159)
Accrued expenses		(294)
Deferred revenue		(662)
Deferred tax liability		(4,867)
Operating lease liability		(2,750)
	$	53,482

Gateway Pharmacology Laboratories LLC

Business Acquisition [Line Items]

Schedule of purchase price allocation

	Preliminary
	Allocation as of
	December 31, 2021
Assets acquired and liabilities assumed:
Accounts receivable		422
Operating lease ROU asset		120
Property and equipment		359
Intangible asset		100
Other assets		9
Goodwill		2,207
Accounts payable		(54)
Accrued expenses		(72)
Deferred tax liability		(118)
Operating lease liability		(120)
	$	2,853

BioReliance Corporation

Business Acquisition [Line Items]

Schedule of purchase price allocation

	Preliminary
	Allocation as of
	December 31, 2021
Assets acquired and liabilities assumed:
Property and equipment		175
Intangible asset		640
	$	815

Plato BioPharma Inc

Business Acquisition [Line Items]

Schedule of purchase price allocation

	Preliminary
	Allocation as of
	December 31, 2021
Assets acquired and liabilities assumed:
Cash		1,027
Accounts receivable		842
Property and equipment		1,148
Operating lease ROU asset		2,582
Intangible asset		5,100
Goodwill		8,898
Operating lease liability		(2,566)
Other liabilities, net		(242)
Deferred tax liability		(1,551)
	$	15,238

Envigo RMS Holding Corp

Business Acquisition [Line Items]

Schedule of purchase price allocation

	Preliminary
	Allocation as of
	December 31, 2021
Assets acquired and liabilities assumed:
Cash		3,287
Trade receivables and contract assets		44,734
Inventory		35,739
Prepaid expenses and other current assets		18,758
Operating lease right-of-use assets, net		7,231
Property and equipment		80,712
Other assets		9,078
Intangible asset		184,000
Goodwill		390,037
Accounts payable		(17,743)
Fees invoiced in advance		(7,283)
Current portion on long-term operating lease		(2,600)
Accrued expenses and other liabilities		(25,884)
Long-term operating leases, net		(4,631)
Long-term deferred tax liabilities		(41,379)
Non-controlling interest		915
	$	674,971

Schedule of information related to measurement assumptions

Stock price	53.31
Strike price	9.93
Volatility	75.93%
Expected term	3.05
Risk-free rate	0.62%

Robinson Services, Inc.

Business Acquisition [Line Items]

Schedule of purchase price allocation

	Preliminary
	Allocation as of
	December 31, 2021
Assets acquired and liabilities assumed:
Customer relationship		4,700
Non-complete agreement		300
Supply agreement		200
Goodwill		948
	$	6,148